Immuno-Biological Laboratories: Financial results for the first quarter of the 2025 fiscal year ending in March, under the Japanese standard (consolidated).
Immuno-Biological Laboratories: Extraordinary Report
Immuno-Biological Laboratories: Confirmation letter
Immuno-Biological Laboratories: Securities report - 42nd period (April 1, 2023 - March 31, 2024)
Immuno-Biological Laboratories: Regarding the correction of some of the numerical data in the "2024 Fiscal Year End Results Briefing (Japanese Standards, Consolidated)".
IMMUNO-BIOLOGICAL LABORATORIES: Financial results presentation materials for the fiscal year ending 2024/3 (42nd term)
IMMUNO-BIOLOGICAL LABORATORIES: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
IMMUNO-BIOLOGICAL LABORATORIES: Notice regarding revisions to full-year earnings forecasts
Institute for Immunobiology: Confirmation
Immunobiological Research Institute: Quarterly Report - 42nd Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Immuno-Biological Laboratories: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Immuno-Biological Laboratories: 2nd quarter financial results presentation for the fiscal year ending 2024/3 (42nd period)
Immuno-Biological Laboratories: Confirmation letter
Immuno-Biological Laboratories: Quarterly Report - 42nd Quarter Second Quarter (2023/07/01 - 2023/09/30)
Immuno-Biological Laboratories: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Immuno-Biological Laboratories: Confirmation letter
Immuno-Biological Laboratories: Quarterly Report - First Quarter 42 (2023/04/01 - 2023/06/30)
Immuno-Biological Laboratories: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Immuno-Biological Laboratories: Extraordinary Report
Immuno-Biological Laboratories: Confirmation letter
No Data
No Data